Editas Medicine Inc (EDIT)
4.67
-0.07
(-1.48%)
USD |
NASDAQ |
Jun 28, 16:00
4.66
-0.01
(-0.21%)
After-Hours: 20:00
Editas Medicine Revenue (Annual): 78.12M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 78.12M |
| December 31, 2022 | 19.71M |
| December 31, 2021 | 25.54M |
| December 31, 2020 | 90.73M |
| December 31, 2019 | 20.53M |
| Date | Value |
|---|---|
| December 31, 2018 | 31.94M |
| December 31, 2017 | 13.73M |
| December 31, 2016 | 6.053M |
| December 31, 2015 | 1.629M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
19.71M
Minimum
2022
90.73M
Maximum
2020
46.93M
Average
25.54M
Median
2021
Revenue (Annual) Benchmarks
| Bristol-Myers Squibb Co | 45.01B |
| Vertex Pharmaceuticals Inc | 9.869B |
| Regeneron Pharmaceuticals Inc | 13.12B |
| Cabaletta Bio Inc | -- |
| Oragenics Inc | -- |